Skip to main content
. 2020 Oct 20;31:101266. doi: 10.1016/j.rmcr.2020.101266

Fig. 2.

Fig. 2

A–C: Changes in pancreatic enlargement from a combination immunochemotherapy.

A: The normal pancreas before administration of a combination immunochemotherapy.

B: The pancreatic enlargement at diagnosis of irAE hepatitis and pancreatitis.

C: The improvement of the pancreatic enlargement after the treatment of PSL and AZA.